Luye Pharma Group (LUP) Stock Forecast & Price Target
LUP Analyst Ratings
Hold
0Buy1Hold0Sell
Based on 1 analysts giving stock ratings to Luye Pharma Group in the past 3 months
LUP Stock 12 Month Forecast
Average Price Target
EUR 0.27▲(48.89% Upside)Based on 1 Wall Street analysts offering 12 month price targets for Luye Pharma Group in the last 3 months. The average price target is EUR 0.27 with a high forecast of EUR 0.27 and a low forecast of EUR 0.27. The average price target represents a 48.89% change from the last price of EUR 0.18.
Past 12 Months12 Month ForecastJan2026Oct2026
HighEUR 0.27
AverageEUR 0.27
LowEUR 0.27
Highest Price TargetHighestEUR 0.27Average Price TargetEUR 0.27Lowest Price TargetLowestEUR 0.27
Detailed List of Analyst Forecasts
Analyst Type
Ranks
Analyst Rating
Upside/ Downside
Action
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
LUP Analyst Recommendation Trends
| Rating | Jun 26 | Jul 26 | Aug 26 | Sep 26 | Oct 26 |
|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 0 | 0 | 0 |
| Buy | 2 | 2 | 2 | 0 | 0 |
| Hold | 0 | 0 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 |
| total | 3 | 3 | 3 | 1 | 1 |
In the current month, LUP has received 0 Buy Ratings, 1 Hold Ratings, and 0 Sell Ratings. LUP average Analyst price target in the past 3 months is 0.27.
LUP Financial Forecast
HighEUR 0.01
ConsensusEUR 0.01
LowEUR 0.01
LUP Earnings Forecast
Next quarter’s earnings estimate for LUP is EUR 0.01 with a range of EUR 0.01 to EUR 0.01. The previous quarter’s EPS was EUR 0.00. Its overall industry beat the EPS estimate 57.80% of the time in the past 12 months.
HighEUR 419M
ConsensusEUR 419M
LowEUR 419M
LUP Sales Forecast
Next quarter’s sales forecast for LUP is EUR 418.85M with a range of EUR 418.85M to EUR 418.85M. The previous quarter’s sales results were EUR 384.72M. Its overall industry beat sales estimates 50.04% of the time in the past 12 months.
LUP Stock Forecast FAQ
What is DE:LUP’s average 12-month price target, according to analysts?
Based on analyst ratings, Luye Pharma Group’s 12-month average price target is €0.27.
What is DE:LUP’s upside potential, based on the analysts’ average price target?
Luye Pharma Group has 48.89% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is Luye Pharma Group a Buy, Sell or Hold?
Luye Pharma Group has a consensus rating of Hold, which is based on 0 buy ratings, 1 hold ratings and 0 sell ratings.
What is Luye Pharma Group’s share price target?
The average share price target for Luye Pharma Group is €0.27. This is based on 1 Wall Street analysts’ 12-month price targets, issued in the past 3 months. The highest analyst share price target is €0.27, and the lowest forecast is €0.27. The average share price target represents a 48.89% increase from the current price of €0.178.
What do analysts say about Luye Pharma Group?
Luye Pharma Group’s analyst rating consensus is a Hold. This is based on the ratings of 1 Wall Street analysts.
How can I buy shares of Luye Pharma Group?
To buy shares of DE:LUP, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.